Optimi Health Acquires Extensive Catalog of Psychedelic and Functional Mushroom Genetics
New strains to provide crucial insights in mental health research across the sector May 17, 2022 VANCOUVER, BC — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce... Read more
REPEAT – Silo Wellness Debuts Marley One, the First Global Functional and Psychedelic Mushroom Brand, in Collaboration with the Bob Marley Family
Ryan Allway June 24th, 2021 Psychedelics MONTEGO BAY, Jamaica, June 24, 2021 (GLOBE NEWSWIRE) — Silo Wellness Inc. (“ Silo Wellness ” or the “ Company ”) (CSE: SILO) (OTC: SILFF) (FRA: 3K70), a leading global psychedelics company, today announced the launch of Marley One, the first global functional and psychedelic mushroom consumer brand,... Read more
Psyence Group Announces Collaboration with the Scientific Research Council (SRC) of Jamaica for Psilocybin Product Development
Ryan Allway June 17th, 2021 Psychedelics TORONTO, June 17, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (“Psyence” or the “Company”) (PSYG:CSE), a public life science biotechnology company pioneering the use of natural psychedelics, is pleased to announce that through its wholly owned Jamaican subsidiary, Psyence Jamaica Limited (“Psyence Jamaica”), it has entered into... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )